Who We Are
The Dedham Group was founded in 2010 to fill a market gap for strategic support within the specialty therapeutics space. Now, we’re not just a preferred vendor for top 10 pharma companies, we’re a go-to business partner, leading the charge with innovative solutions for the life sciences industry.
Market Access, Simplified
TDG leverages deep commercial and access expertise with proprietary analytics to provide highly differentiated recommendations and strategic support for specialty therapeutics in and outside the U.S.
Our mission is to partner with life sciences organizations to help them hone their business strategies and achieve their goals, using our proprietary and third-party data to provide unique, actionable insights that fuel business results and boost your bottom line.
Mission-Driven and Team-Oriented
At The Dedham Group, our client-first, collaborative culture is the engine that fuels our success—and yours.
As part of the Norstella family of solution providers, we collaborate seamlessly with our sister brands: Citeline, Evaluate, MMIT, and Panalgo. Together, we’re a powerhouse alliance that connects the dots from pipeline to patient. Are you ready to simplify market access and revolutionize the life sciences landscape? The Dedham Group is your springboard to success. Let’s talk.
Customer Centricity In Action
VP, Oncology Franchise
“With so much change and noise, it’s hard to focus our people and resources, and no one is closer to the customer than Dedham, which gives us a huge competitive edge on a daily basis.”
Executive Director, Market Access
“The Dedham Group is very data driven and their output is always actionable, especially because they know how to help us implement… we rely heavily on them as a priority partner.”
Ready to get started? Contact us.
